CGEM Financials

Cullinan Therapeutics Inc - Financial statements & key metrics

Stock Price

$15.06

Market Cap

$892.16M

EPS

$-3.36

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-167.57M

EPS (Diluted)

Balance Sheet Highlights

Total Assets

$621.82M

Total Liabilities

$31.50M

Shareholders Equity

Cash & Equivalents

$83.00M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-145.30M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-0.4%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is CGEM revenue?

View CGEM's income statement for detailed revenue data.

Is CGEM profitable?

CGEM reported a loss of $167.57M in the most recent quarter.

What is CGEM market cap?

CGEM has a market capitalization of $892.16M, making it a small-cap stock.

Does CGEM have debt?

View CGEM's balance sheet for debt information.

What is CGEM cash flow?

Cash flow data is available in the full financial statements.